Elscint and its parent company Elbit Medical Imaging have announced a restructuring that will focus the Haifa, Israel-based firm’s activities in the hotel and leisure sectors. As part of this plan, Elscint has acquired the hotels division of Europe
Elscint and its parent company Elbit Medical Imaging have announced a restructuring that will focus the Haifa, Israel-based firms activities in the hotel and leisure sectors. As part of this plan, Elscint has acquired the hotels division of Europe Israel, which is the controlling shareholder of EMI. Elscint has also acquired an entertainment and commercial center. The impact on Elscints medical imaging assets was not immediately clear.
Earlier last week, Elscint and EMI announced that EMI has decided to terminate discussions on the proposed business combination between the two companies. Elscint had received an offer earlier this year for the purchase of their outstanding shares for about $200 million (SCAN 3/3/99).
Elscints recent business decisions have not been popular with all of its shareholders. Shareholder and former president Yonatan Aderet has filed a claim in the District Court of Tel Aviv, alleging that the former directors of the company caused damage to the company and discriminated against the firms minority shareholders by their actions, including their decisions regarding the sale of Elscints assets.
Aderets motion was submitted on behalf of all existing shareholders of the company, who were either shareholders or holders of options convertible to company shares before Nov. 5, 1998. He has requested that the company be ordered to purchase from each member of the represented group all shares held by them at a price of not less than $28 per share. Alternatively, he has requested that Elscint be directed to publish an acquisition proposal for the purchase of its shares held by the public at a price of $28. Elscint believes Aderets claim is devoid of factual and legal merit, and intends to vigorously oppose it.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.